Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3642944013 | Product containing durvalumab (medicinal product) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 3642945014 | Product containing durvalumab | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3669457015 | Durvalumab product | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3714580014 | Durvalumab-containing product | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 110938601000001113 | Durvalumab | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT United Kingdom Edition module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing durvalumab | Has active ingredient | Durvalumab | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing durvalumab | Is a | Product containing monoclonal antibody | false | Inferred relationship | Existential restriction modifier | ||
| Product containing durvalumab | Plays role | Antineoplastic therapeutic role | true | Inferred relationship | Existential restriction modifier | ||
| Product containing durvalumab | Is a | Medicinal product acting as antineoplastic agent (product) | false | Inferred relationship | Existential restriction modifier | ||
| Product containing durvalumab | Is a | Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing durvalumab | Is a | Virtual therapeutic moiety | false | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing durvalumab in parenteral dose form (medicinal product form) | Is a | True | Product containing durvalumab | Inferred relationship | Existential restriction modifier | |
| Durvalumab | Is a | True | Product containing durvalumab | Inferred relationship | Existential restriction modifier | |
| Durvalumab 500mg/10ml solution for infusion vials | Is a | False | Product containing durvalumab | Inferred relationship | Existential restriction modifier | |
| Durvalumab 120mg/2.4ml solution for infusion vials | Is a | False | Product containing durvalumab | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets